News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,873 Results
Type
Article (44456)
Company Profile (344)
Press Release (707061)
Multimedia
Podcasts (151)
Webinars (24)
Section
Business (239588)
Career Advice (2052)
Deals (36283)
Drug Delivery (145)
Drug Development (84256)
Employer Resources (174)
FDA (16859)
Job Trends (15248)
News (354931)
Policy (33314)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2699)
Accelerated approval (60)
ADA (49)
Adcomms (33)
Allergies (199)
Alliances (51119)
ALS (237)
Alzheimer's disease (1927)
Antibody-drug conjugate (ADC) (561)
Approvals (17312)
Artificial intelligence (779)
ASCO (337)
Autoimmune disease (365)
Automation (63)
Bankruptcy (376)
Best Places to Work (11839)
BIO (74)
BIOSECURE Act (20)
Biosimilars (244)
Biotechnology (243)
Bladder cancer (210)
Brain cancer (79)
Breast cancer (827)
Cancer (6544)
Cardiovascular disease (534)
Career advice (1749)
Career pathing (47)
CAR-T (372)
CDC (60)
Celiac Disease (3)
Cell therapy (1021)
Cervical cancer (56)
Clinical research (73585)
Collaboration (2356)
Commercialization (1)
Company closure (5)
Compensation (1563)
Complete response letters (98)
COVID-19 (2820)
CRISPR (127)
C-suite (1317)
Cystic fibrosis (167)
Data (8876)
Decentralized trials (3)
Denatured (47)
Depression (191)
Dermatology (104)
Diabetes (685)
Diagnostics (7122)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (391)
Drug pricing (215)
Drug shortages (32)
Duchenne muscular dystrophy (329)
Earnings (93576)
Editorial (73)
Employer branding (21)
Employer resources (156)
Events (124534)
Executive appointments (1178)
FDA (20997)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (1956)
Gene editing (272)
Generative AI (65)
Gene therapy (822)
GLP-1 (1151)
Government (4856)
Grass and pollen (6)
Guidances (422)
Healthcare (19493)
Hematology (194)
HIV (93)
Huntington's disease (66)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (118)
Immunology and inflammation (339)
Immuno-oncology (116)
Indications (225)
Infectious disease (3197)
Inflammatory bowel disease (235)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (327)
Interviews (321)
IPO (16976)
IRA (53)
Job creations (3721)
Job search strategy (1444)
JPM (67)
Kidney cancer (21)
Labor market (112)
Layoffs (613)
Leadership (44)
Legal (8033)
Liver cancer (105)
Longevity (36)
Lung cancer (866)
Lymphoma (487)
Machine learning (66)
Management (61)
Manufacturing (1201)
Marketing (5)
MASH (219)
Medical affairs (1)
Medical device (14161)
Medtech (14342)
Mergers & acquisitions (20639)
Metabolic disorders (1739)
mRNA (263)
Multiple sclerosis (208)
NASH (20)
Neurodegenerative disease (501)
Neuropsychiatric disorders (120)
Neuroscience (3664)
Neurotech (1)
NextGen: Class of 2026 (6776)
Non-profit (4614)
Now hiring (83)
Obesity (812)
Opinion (323)
Ovarian cancer (246)
Pain (277)
Pancreatic cancer (365)
Parkinson's disease (418)
Partnered (37)
Patents (656)
Patient recruitment (810)
Peanut (68)
People (61453)
Pharmaceutical (57)
Pharmacy benefit managers (34)
Phase 1 (23139)
Phase 2 (32473)
Phase 3 (23976)
Pipeline (10189)
Policy (349)
Postmarket research (2608)
Preclinical (9903)
Press Release (67)
Prostate cancer (349)
Psychedelics (70)
Radiopharmaceuticals (372)
Rare diseases (1279)
Real estate (6085)
Recruiting (72)
Regulatory (26482)
Reports (56)
Research institute (2525)
Resumes & cover letters (356)
Rett syndrome (46)
RNA editing (30)
RSV (90)
Schizophrenia (192)
Series A (338)
Series B (249)
Service/supplier (7)
Sickle cell disease (132)
Special edition (30)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (3846)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (88)
The Weekly (101)
Vaccines (1190)
Venture capital (133)
Weight loss (524)
Women's health (143)
Worklife (22)
Date
Last 7 days (418)
Last 30 days (1874)
Last 365 days (31230)
2026 (17262)
2025 (31055)
2024 (36162)
2023 (41011)
2022 (52276)
2021 (56759)
2020 (54917)
2019 (47413)
2018 (35693)
2017 (33021)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (760)
Alabama (101)
Alaska (7)
Arizona (377)
Arkansas (16)
Asia (41498)
Australia (6912)
California (14369)
Canada (4036)
China (1584)
Colorado (616)
Connecticut (634)
Delaware (439)
Europe (91352)
Florida (2157)
Georgia (456)
Hawaii (3)
Idaho (63)
Illinois (1187)
India (102)
Indiana (641)
Iowa (25)
Japan (610)
Kansas (137)
Kentucky (54)
Louisiana (59)
Maine (78)
Maryland (1696)
Massachusetts (10422)
Michigan (380)
Minnesota (776)
Mississippi (6)
Missouri (154)
Montana (35)
Nebraska (30)
Nevada (151)
New Hampshire (89)
New Jersey (3768)
New Mexico (33)
New York (3758)
North Carolina (1861)
North Dakota (10)
Northern California (7253)
Ohio (427)
Oklahoma (23)
Oregon (43)
Pennsylvania (2836)
Puerto Rico (31)
Rhode Island (52)
South America (1127)
South Carolina (89)
South Dakota (2)
Southern California (5686)
Tennessee (234)
Texas (2294)
United States (50802)
Utah (427)
Vermont (2)
Virginia (349)
Washington D.C. (82)
Washington State (1168)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
751,873 Results for "evolveimmune therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
April 28, 2026
·
2 min read
Press Releases
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
April 22, 2026
·
5 min read
Press Releases
EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting
April 14, 2026
·
3 min read
Press Releases
EvolveImmune Therapeutics Announces Initiation of Dosing in a Phase 1 Trial of EVOLVE104 in Patients with Solid Tumors
December 16, 2025
·
3 min read
Press Releases
EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation
August 15, 2025
·
2 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
·
5 min read
Press Releases
ChemDiv, Inc. Highlights Successful Deployment of Proprietary CNS Drug Discovery Platform, Advancing Neurodegenerative Programs for Polku Therapeutics and Brenig Therapeutics
June 22, 2026
·
2 min read
Press Releases
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
·
5 min read
1 of 75,188
Next
